PHOSPHAGENICS Aktie

0,13 EUR 0,8065%

Zu Ihrem Onlinebroker

kaufen verkaufen

PHOSPHAGENICS Aktienkurs : 08:24 ( 15 Min. verzögert)
0,125 € Letzter Kurs	0,81% Veränderung	0,124 € Vortag	0,125 € Eröffnungskurs

Realtime:

0,13

0,81%

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,125 - 0,125 Tag	0,181 - 0,0670 52 Wochen	0 Tag	358 Ø 52 Wochen	0,125 15.000 Stücke	0,145 15.000 Stücke

PHOSPHAGENICS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

24.05.

Phosphagenics taps Labtec for pain patch design

... the aid of Germany's Labtec to help design the final version of drug delivery patch TPM/oxycodone, ahead of phase III trials. Phosphagenics (ASX:POH) has engaged Germany's Labtec GmbH to help design the final ...
21.05.

PHOSPHAGENICS LIMITED : 2012 May 21 Phosphagenics to Launch BodyShaper in UK ...

21 May 2012, Melbourne, Australia: Australian drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) today announced that its BodyShaper anti-cellulite product will be launched in the United Kingdom on...

18.05.

Fund official gains from poor investment

... chief executive of the Meat Industry Employees Superannuation Fund, Jon Addison, who was subsequently elevated to non-executive chairman of biotech company Phosphagenics.
11.05.

Phosphagenics lands retail deal with David Jones

Retail chain David Jones has agreed to stock the Elixia range of skincare products from Melbourne-based Phosphagenics (ASX:POH). Phosphagenics (ASX:POH) has signed on David Jones as its newest retail partner for its Elixia range of skincare products.